{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_11128", "batch_size": 260, "batch_pos": 78, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 2, "answer": "no", "rationale": "The segment uses factual language ('began', 'modified') without high-potency verbs, metaphors, superlatives, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_13428", "batch_size": 260, "batch_pos": 67, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 3, "answer": "no", "rationale": "The segment uses plain verbs ('began', 'modified') not moderate verbs with scale/impact.", "method": "llm_batch", "batch_id": "batch_3_17768", "batch_size": 260, "batch_pos": 50, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_2156", "batch_size": 260, "batch_pos": 49, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 5, "answer": "no", "rationale": "Reports company research history, lacking explicit calming language or required tokens.", "method": "llm_batch", "batch_id": "batch_5_18320", "batch_size": 260, "batch_pos": 47, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast pattern found.", "method": "llm_batch", "batch_id": "batch_6_16540", "batch_size": 260, "batch_pos": 32, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 7, "answer": "no", "rationale": "The segment discusses vaccine research history but contains no bare negation.", "method": "llm_batch", "batch_id": "batch_7_15092", "batch_size": 260, "batch_pos": 28, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 8, "answer": "no", "rationale": "Describes historical development of a technology.", "method": "llm_batch", "batch_id": "batch_8_4924", "batch_size": 260, "batch_pos": 225, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 9, "answer": "no", "rationale": "The segment discusses research history, not reporting prices or metrics.", "method": "llm_batch", "batch_id": "batch_9_10392", "batch_size": 260, "batch_pos": 16, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 10, "answer": "no", "rationale": "The segment provides a factual statement about research history.", "method": "llm_batch", "batch_id": "batch_10_9812", "batch_size": 260, "batch_pos": 6, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 11, "answer": "no", "rationale": "Quoted source provides factual information without framing language.", "method": "llm_batch", "batch_id": "batch_11_18148", "batch_size": 260, "batch_pos": 4, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 12, "answer": "yes", "rationale": "Factual report about research history without explicit framing cues.", "method": "llm_batch", "batch_id": "batch_12_6400", "batch_size": 260, "batch_pos": 4, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
